相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A low-dose combination of valsartan and low molecular weight heparin better improved glomerular permeability than did high-dose monotherapy in rats with diabetic nephropathy
Bo Jiao et al.
DRUG DISCOVERIES AND THERAPEUTICS (2011)
Diabetic neuropathy: therapies on the horizon
Danish Mahmood et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
DIABETES Podocytes lose their footing
Christian Rask-Madsen et al.
NATURE (2010)
Very high doses of valsartan provide renoprotection independently of blood pressure in a type 2 diabetic nephropathy rat model
Naoto Tominaga et al.
NEPHROLOGY (2009)
Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats
Manuel Portero-Otin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Z. Zhang et al.
KIDNEY INTERNATIONAL (2008)
Podocyte biology in diabetic nephropathy
J. J. Li et al.
KIDNEY INTERNATIONAL (2007)
Activation of the renin-angiotensin system within podocytes in diabetes
T-H Yoo et al.
KIDNEY INTERNATIONAL (2007)
Cytokines in glomerulonephritis
Peter G. Tipping et al.
SEMINARS IN NEPHROLOGY (2007)
Oxidants in chronic kidney disease
Sudhir V. Shah et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Insight on the Pathogenesis of Diabetic Nephropathy from the Study of Podocyte and Mesangial Cell Biology
Gabriella Gruden et al.
CURRENT DIABETES REVIEWS (2005)
The intrarenal renin-angiotensin system and diabetic nephropathy
RM Carey et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2003)
ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1
B Amann et al.
DIABETES CARE (2003)
Overview of glucose signaling in mesangial cells in diabetic nephropathy
M Haneda et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
The AT1-type angiotensin receptor in oxidative stress and atherogenesis part I:: Oxidative stress and atherogenesis
G Nickenig et al.
CIRCULATION (2002)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Protein kinase C activation and its pharmacological inhibition in vascular disease
M Meier et al.
VASCULAR MEDICINE (2000)
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
T Nishikawa et al.
NATURE (2000)
Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose
HJ Ha et al.
KIDNEY INTERNATIONAL (2000)
分享论文
